Wells Fargo Downgrades Quest Diagnostics To Underperform

By: via Benzinga
Analysts at Wells Fargo downgraded Quest Diagnostics Inc. (NYSE: DGX) from Market Perform to Underperform. Quest Diagnostics shares ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.